Even within the myopathies classified as Brody’s disease, there is a degree of heterogeneity in the ATP2A1 mutations as they have been documented in the A-, P-, and N-domains as well as several others at various points along the transmembrane helices [126]. This evidence concerns the gene ATP2A1 and Brody myopathy.